ASCLEPIOS S.A. secures contract for Pharmaceutical products - Delivery of drugs used in the treatment of pulmonary arterial hypertension (PAH) - Drug program

Poland, Dec. 19 -- Poland based ASCLEPIOS S.A. has secured contract from Uniwersytecki Szpital Kliniczny w Olsztynie for Pharmaceutical products - Delivery of drugs used in the treatment of pulmonary arterial hypertension (PAH) - Drug program. The value of the contract is worth 21571200 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....